Offerings // AVITA Medical, Inc.

RCEL offering history

Every offering-related filing in AVITA Medical, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 376 filings back to Dec 19, 2018.

Last executed offering

Jun 8, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Mar 31, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jun 8, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 9, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 31, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jan 13, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 18, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 8, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 14, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 18, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 25, 2023	424B2 →	EXECUTED	Prospectus supplement priced — shares or notes (large filers: often a bond deal)
Apr 25, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 14, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Feb 26, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 24, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 16, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 9, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet

RCEL offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full RCEL workspace →

RCEL offering FAQ

When did RCEL last execute an offering?

Per SEC filings, AVITA Medical, Inc.'s most recent priced offering document is a 424B5 filed 2026-06-08. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did RCEL last announce or register an offering?

The most recent registration is a S-3 filed 2026-03-31. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.